Camac Fund, LP's Form 4 filing
Pasithea Therapeutics Corp. (KTTA) · filed Sep 30, 2022
- Accession no.
- 0001209191-22-051650
- Filed
- Sep 30, 2022, 4:36 PM ET
- Trade date
- Sep 28-29, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $76.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Camac Fund, LPCIK 0001516478 | Other: Member of 10% owner group |
| Shahinian EricCIK 0001790877 | Other: Member of 10% owner group |
| Camac Partners, LLCCIK 0001867496 | Other: Member of 10% owner group |
| Camac Capital, LLCCIK 0001867498 | Other: Member of 10% owner group |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 28, 2022 | Common Stock | PPurchaseAcquired | +57,647 | $1.19 | +$68,542.28 | 1,781,705 | Indirect | |
| Sep 29, 2022 | Common Stock | PPurchaseAcquired | +6,710 | $1.16 | +$7,756.76 | 1,788,415 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.